Seeking Alpha

Par Pharmaceutical (PRX -2.7%) trades lower after saying late Friday that it's challenging a...

Par Pharmaceutical (PRX -2.7%) trades lower after saying late Friday that it's challenging a federal rule that it claims infringes on its first-amendment right to promote its anorexia treatment Megace ES. Doctors feel the drug could benefit a variety of patients outside the FDA approved AIDS-only spectrum, but the company says the FDA is blocking it from discussing treatment options.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector